HLA-G polymorphisms and HLA-G expression in sarcoidosis

Sarcoidosis Vasc Diffuse Lung Dis. 2006 Mar;23(1):30-7.

Abstract

Background: The MHC class Ib molecule Human Leukocyte Antigen (HLA)-G may be important in induction and maintenance of immunological tolerance, and HLA-G expression may have a role in different cancers, in certain diseases with associations to HLA, and in organ transplantation. Sarcoidosis is a systemic granulomatous disease with unknown etiology but at the molecular level several studies have shown HLA associations.

Methods: In the present study, HLA-G alleles/polymorphisms were studied in sarcoidosis patients (n = 47) and controls (n = 129) by PCR techniques and HLA-G protein expression was investigated in granulomas from sarcoidosis patients with the use of immunohistochemistry.

Results: The HLA-G*010102/-G*0106 alleles were observed more often in sarcoidosis patients (39.4%) than in controls (26.4%), p = 0.025 (Fisher's exact test); however, not significant after correction (p(c) = 0.15). When HLA-G expression was investigated by immunohistochemistry in granulomas from sarcoidosis patients, weak HLA-G expression was observed in only one patient.

Conclusions: HLA-G alleles that include a 14-bp sequence polymorphism in exon 8 of the HLA-G gene are observed more often in sarcoidosis patients than in controls. The sequence variation may influence HLA-G mRNA stability and influence the expression of soluble isoforms of HLA-G. Only rare and weak expression of HLA-G was observed in granulomas from sarcoidosis patients. More studies are needed to further elucidate the possible role for HLA-G in sarcoidosis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Alleles
  • Female
  • Gene Frequency
  • HLA Antigens / genetics*
  • Histocompatibility Antigens Class I / genetics*
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Polymorphism, Genetic*
  • RNA, Messenger / metabolism
  • Sarcoidosis / genetics*
  • Sarcoidosis / immunology*
  • Sequence Analysis, DNA

Substances

  • HLA Antigens
  • Histocompatibility Antigens Class I
  • RNA, Messenger